A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects

Summary

A Randomized Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Timeline

Start

2021-09-25

Primary completion

2022-07-18

Completion

2022-07-18

Outcome

Outcome not reported

Stopped: “ALT flares suggestive of drug induced liver injury”

Drugs

Indications